MatchTope: A tool to predict the cross reactivity of peptides complexed with Major Histocompatibility Complex I

The therapeutic targeting of the immune system, for example in vaccinology and cancer treatment, is a challenging task and the subject of active research. Several in silico tools used for predicting immunogenicity are based on the analysis of peptide sequences binding to the Major Histocompatibility...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 13; p. 930590
Main Authors Mendes, Marcus Fabiano de Almeida, de Souza Bragatte, Marcelo, Vianna, Priscila, de Freitas, Martiela Vaz, Pöhner, Ina, Richter, Stefan, Wade, Rebecca C., Salzano, Francisco Mauro, Vieira, Gustavo Fioravanti
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 28.10.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The therapeutic targeting of the immune system, for example in vaccinology and cancer treatment, is a challenging task and the subject of active research. Several in silico tools used for predicting immunogenicity are based on the analysis of peptide sequences binding to the Major Histocompatibility Complex (pMHC). However, few of these bioinformatics tools take into account the pMHC three-dimensional structure. Here, we describe a new bioinformatics tool, MatchTope, developed for predicting peptide similarity, which can trigger cross-reactivity events, by computing and analyzing the electrostatic potentials of pMHC complexes. We validated MatchTope by using previously published data from in vitro assays. We thereby demonstrate the strength of MatchTope for similarity prediction between targets derived from several pathogens as well as for indicating possible cross responses between self and tumor peptides. Our results suggest that MatchTope can enhance and speed up future studies in the fields of vaccinology and cancer immunotherapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Brian M. Baker, University of Notre Dame, United States
These authors share first authorship
Reviewed by: Yajuan Zhu, Sichuan University, China; Lydia E. Kavraki, Rice University, United States
This article was submitted to T Cell Biology, a section of the journal Frontiers in Immunology
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2022.930590